Company Quick10K Filing
Boston Therapeutics
10-K 2019-12-31 Filed 2020-06-08
10-Q 2019-09-30 Filed 2019-11-19
10-Q 2019-06-30 Filed 2019-08-19
10-Q 2019-03-31 Filed 2019-05-20
10-K 2018-12-31 Filed 2019-04-16
10-Q 2018-09-30 Filed 2018-11-14
10-Q 2018-06-30 Filed 2018-08-14
10-Q 2018-03-31 Filed 2018-05-14
10-K 2017-12-31 Filed 2018-03-27
10-Q 2017-09-30 Filed 2017-11-13
10-Q 2017-06-30 Filed 2017-08-10
10-Q 2017-03-31 Filed 2017-05-11
10-K 2016-12-31 Filed 2017-03-28
10-Q 2016-09-30 Filed 2016-11-10
10-Q 2016-06-30 Filed 2016-08-15
10-Q 2016-03-31 Filed 2016-05-11
10-K 2015-12-31 Filed 2016-03-30
10-Q 2015-09-30 Filed 2015-11-20
10-Q 2015-06-30 Filed 2015-08-13
10-Q 2015-03-31 Filed 2015-05-20
10-K 2014-12-31 Filed 2015-03-27
10-Q 2014-09-30 Filed 2014-11-07
10-Q 2014-06-30 Filed 2014-08-08
10-Q 2014-03-31 Filed 2014-05-13
10-K 2013-12-31 Filed 2014-03-14
10-Q 2013-09-30 Filed 2013-11-13
10-Q 2013-06-30 Filed 2013-08-09
10-Q 2013-03-31 Filed 2013-05-15
10-K 2012-12-31 Filed 2013-04-04
10-Q 2012-09-30 Filed 2012-11-14
10-Q 2012-06-30 Filed 2012-08-14
10-Q 2012-03-31 Filed 2012-05-18
10-K 2011-12-31 Filed 2012-03-30
10-Q 2011-09-30 Filed 2011-11-14
10-Q 2011-06-30 Filed 2011-08-15
10-Q 2011-03-31 Filed 2011-05-16
10-K 2010-12-31 Filed 2011-04-01
10-Q 2010-09-30 Filed 2010-11-23
8-K 2020-05-15
8-K 2020-04-14
8-K 2020-01-10
8-K 2019-12-12
8-K 2019-12-02
8-K 2019-09-24
8-K 2018-11-30
8-K 2018-06-26
8-K 2018-06-12
8-K 2018-06-01
8-K 2018-02-12

Boston Therapeutics Financials

BTHE Metrics, Comps, Filings

Quarterly | Annual

Valuation ($MM)

Market Cap, Enterprise Value

Balance Sheet ($MM)

Assets, Equity

Income Statement ($MM Quarterly)

Revenue, G Profit, Net Income

Cash Flow ($MM Quarterly)

Ops, Inv, Fin

Comps ($'000 TTM) Market Cap Gross Margin EV/EBITDA Ret on Assets Assets Liabilities Revenue G Profit Net Income EBITDA EV
Pressure Biosciences (PBIO) 7,038 41% -1.9 -331% 2,411 12,035 1,530 630 -7,979 -3,691 6,902
MGT Capital Investments (MGTI) 7,028 -31% -0.6 -144% 5,265 1,955 190 -58 -7,582 -7,576 4,915
International Stem Cell (ISCO) 7,018 62% -5.0 -19% 8,260 4,636 6,635 4,138 -1,551 -1,322 6,555
Star Gold (SRGZ) 6,966 -29.3 -31% 751 35 0 0 -235 -235 6,865
Westmoreland Coal (WLB) 6,952 22% -73.7 -15% 1,467,857 2,190,755 1,264,675 282,069 -219,134 -13,208 973,082
Vaso (VASO) 6,906 54% -5.8 -7% 45,928 43,364 51,794 28,138 -3,037 -964 5,563
Scientific Industries (SCND) 6,822 43% 6.9 5% 8,863 2,553 10,165 4,402 447 801 5,562
Vitality Biopharma (VBIO) 6,792 0% -0.2 -324% 4,197 1,644 95 0 -13,584 -13,577 2,833
Avant Diagnostics (AVDX) 6,739 -3.1 -52% 4,907 3,030 0 0 -2,557 -2,262 6,910
Video Display (VIDE) 6,701 25% -52.2 -3% 9,802 5,465 13,711 3,469 -313 -119 6,215
Boston Therapeutics (BTHE) 6,668 0% -4.7 -207% 743 6,362 13 0 -1,537 -1,423 6,659
China Xuefeng Environmental (CXEE) 6,652 59% -1.6 6% 87,699 19,594 14,414 8,439 5,217 9,810 -16,127
Textmunication Holdings (TXHD) 6,569 61% -2.2 -559% 541 566 758 460 -3,023 -3,023 6,668
IIoT-OXYS (ITOX) 6,490 70% -4.6 -341% 491 2,218 114 80 -1,676 -1,552 7,096
ETF Managers Group Commodity Trust I (RISE) 6,472 6.4 12% 8,210 25 0 0 1,009 1,009 6,472
Global Digital Solutions (GDSI) 6,377 -2.2 -2,467% 83 5,129 0 0 -2,045 -2,866 6,326
Madison Technologies (MDEX) 6,320 48% -228.5 -194% 14 358 3 1 -28 -28 6,315
Rocky Mountain High Brands (RMHB) 6,308 -23% -1.7 354,870,400% 467 -108 -3,549 -4,176 6,891
Opti (OPTI) 6,289 19.4 68,700,000% 0 0 -687 -787 -15,294
Financial Gravity Companies (FGCO) 6,239 99% -26.4 -33% 1,637 363 3,087 3,042 -533 -236 6,232

Balance Sheet ($'000)2011-09-302011-12-312012-03-312012-06-302012-09-302012-12-312013-03-312013-06-302013-09-302013-12-312014-03-312014-06-302014-09-302014-12-312015-03-312015-06-302015-09-302015-12-312016-03-312016-06-302016-09-302016-12-312017-03-312017-06-302017-09-302017-12-312018-03-312018-06-302018-09-302018-12-312019-03-312019-06-302019-09-30
Cash33622626418169552385133,8643,3872,5121,5095691572202085841412192368739013229713720536311128119
Accounts Receivable81721121710043094031358511111110010
Inventory1224252524172516519011198173178198180127186110104103100555554423937321876
PP&E47799101518181714131198643243343332211
Assets1,2611,1509431,3171,0641,4351,3021,0605,1344,5353,4702,5661,7041,1631,2351,1261,0138788531,1711,6971,4051,0991,0471,1879043,4814,0984,2931,439930821743
Accounts Payable2173423213363522943563641151717296287411519659859575554523287319350297271299527481524510551595592
Long-Term Debt4974971,6021,7521,75236559379300
Liabilities6167257027688087398118346401,1906127929601,0881,4992,1371,6951,4091,4011,6976,4974,5244,9134,6655,6434,7875,9206,5775,8445,5855,9926,1516,362
Stockholders' Equity6454252415492566964902264,4943,3452,8571,77474375-264-1,011-682-531-548-526-4,801-3,119-3,815-3,618-4,456-3,884-3,577-3,616-2,688-4,146-5,061-5,329-5,619
Income Statement ($'000)2011-09-302011-12-312012-03-312012-06-302012-09-302012-12-312013-03-312013-06-302013-09-302013-12-312014-03-312014-06-302014-09-302014-12-312015-03-312015-06-302015-09-302015-12-312016-03-312016-06-302016-09-302016-12-312017-03-312017-06-302017-09-302017-12-312018-03-312018-06-302018-09-302018-12-312019-03-312019-06-302019-09-30
Revenue11192131923232188044211211351395412161259454159138454
Cost of Revenue3128229164829119104552282173267509216917529618
Gross Profit-2-0-9-2-73-25-699-23-11-139-419-28-45-87-48-66-4-1-13
R&D94675268112332922152342269530519232205974742220162642481896438540488383387
SG&A2482151922065745436097821,0571,9281,2781,014674520549386371301233166495292249203264351680726316245227257
Tax000000003011500-140-440000000000
Net Income-349-286-257-191-366-578-667-519-1,117-2,298-1,566-1,211-1,160-762-676-686-534-593-419-368-4,6201,669-7084,022-972-16-2,743-132765-952-282-303
Cash Flow ($'000)2011-09-302011-12-312012-03-312012-06-302012-09-302012-12-312013-03-312013-06-302013-09-302013-12-312014-03-312014-06-302014-09-302014-12-312015-03-312015-06-302015-09-302015-12-312016-03-312016-06-302016-09-302016-12-312017-03-312017-06-302017-09-302017-12-312018-03-312018-06-302018-09-302018-12-312019-03-312019-06-302019-09-30
Cash Operating-110-200-166-245-242-415-372-1,036-516-1,121-1,001-939-412-369-12-246-667-402-169-442-236-294-453-255-211-269-31-54-386-404
Cash Investing00-4-3-20-2-6-4-2000000000-30-1400000
Cash Financing00562062525004,889462500004320976504021501,34401959627510030650389402